Concepedia

Publication | Open Access

Erythropoietin and Protection of Renal Function in Cardiac Surgery (the EPRICS Trial)

46

Citations

38

References

2014

Year

Abstract

Intravenous administration of a single high-dose (400 IU/kg) erythropoietin did not have a renal protective effect on patients with reduced kidney function undergoing coronary artery bypass surgery.

References

YearCitations

Page 1